Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

mesenchymal

mesenchymal is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 45
News articles 0
Drug details — mesenchymal
Class
—
Route
—
Patents
20
Programs
45
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

mesenchymal is an FDA-listed pharmaceutical active ingredient.

Key facts

INN mesenchymal

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. Mesenchymal Stromal Cells Phase 3 · Chinese Academy of · Chronic Graft-Versus-Host Disease
  2. 2025-521877-14-00 Phase 2 · George Institute for · Traumatic spinal cord injury
  3. 2G-MSC-GVHD Phase 2 · George Institute for · Patients who have developed acute GVHD refractory to cortico
  4. ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS Phase 2 · Lxo Ireland Designated · Sars-CoV2
  5. APHP211026 Phase 2 · PARItec · Systemic sclerosis
  6. Adult Allogeneic Mesenchymal cells from adipose tissue. Phase 2 · Lxo Ireland Designated · Acute Graft Versus Host Disease
  7. Autologous adipose derived mesenchymal stem cells Phase 2 · Lxo Ireland Designated · Critical Limb Ischemia (CLI)
  8. Autologous mesenchymal stem cells from adipose tissue. Phase 2 · Lxo Ireland Designated · Autoimmune Diseases

Related patents

Browse patents

  1. US 12274684

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12263165

    Small molecule inhibitors of cancer stem cells and mesenchymal cancer types

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12226437

    Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12209255

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12171786

    Use of mesenchymal stem cells for the treatment of inflammation

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12116596

    Method and apparatus for improved mesenchymal stem cell harvesting

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12064453

    Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11857575

    Mesenchymal stem cell-derived exosomes and their uses

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11839596

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11802272

    Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11759461

    Small molecule inhibitors of cancer stem cells and mesenchymal cancer types

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11666602

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11655454

    Method and apparatus for improved mesenchymal stem cell harvesting

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11529373

    Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11185572

    Mesenchymal stem cells for the treatment of CNS diseases

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11186873

    Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11141393

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10842826

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10660918

    Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10564149

    Populations of mesenchymal stem cells that secrete neurotrophic factors

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is mesenchymal?

mesenchymal is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.